NYGC
At the annual AGBT General Meeting, early Ultima customers shared their experiences using the new instrument to satisfy their most sequencing-intensive applications.
Bipolar Funding Consortium Aims to Unravel Disorder's Genetics, Reduce Healthcare Disparities
Premium
The ambitious set of projects funded by BD² aims to improve our understanding of bipolar disorder and inform care across the entire spectrum of research and clinical practice.
Bipolar Disorder Research Funding Organization Awards $18M in Grants to NYGC, Others
BD², a collaboration between three family philanthropies and the Milken Institute, awarded grants to teams at the New York Genome Center, Harvard, Stanford, and Yale.
The five centers, funded as part of NIH's Somatic Mosaicism across Human Tissues Network, will analyze over 2,200 samples to study somatic variants in humans.
NY Genome Center Team Harnesses Ultima Genomics Platform for High-Sensitivity ctDNA Sequencing
Premium
Taking advantage of the new platform's low sequencing cost, the researchers sequenced cell-free circulating DNA (ccfDNA) in plasma at high depth for sensitive cancer monitoring.